Lipid disorders among Black Africans non-users of lipid-lowering medication

Borgo, Mariana Veronez; Baldo, Marcelo Perim; Alvim, Rafael de Oliveira; Zaniqueli, Divanei; Capingana, Daniel P.; Magalhães, Pedro; Silva, Amilcar Bernardo da; Oliosa, Polyana Romano; Sartório, Carmem Luíza; Mill, José Geraldo

doi:10.20945/2359-3997000000076

Cited by 5 publications

(2 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Cardiovascular diseases (CVDs), mainly ischaemic heart disease and stroke, are the leading causes of morbidity and mortality globally and in Sub-Saharan Africa [1][2][3]. Dyslipidaemia, hypertension, and diabetes mellitus (DM) are major risk factors for CVDs [2,4].…”

Section: Introductionmentioning

confidence: 99%

“…Dyslipidaemia, hypertension, and diabetes mellitus (DM) are major risk factors for CVDs [2,4]. Dyslipidaemia drives the process of atherosclerosis [1] and is a significant modifiable risk factor among persons with hypertension and diabetes [5][6][7]. Dyslipidaemia, through its associated complications, accounts for over 2 million annual deaths and nearly 30 million disabilities globally [8].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

High prevalence of dyslipidaemia among persons with diabetes mellitus and hypertension at a tertiary hospital in Blantyre, Malawi

Katundu

Mukhula

Phiri

et al. 2022

BMC Cardiovasc Disord

View full text Add to dashboard Cite

Background Dyslipidaemia drives the process of atherosclerosis, and hence a significant modifiable risk factor complicating hypertension and diabetes. In Malawi, the prevalence, screening and management of dyslipidaemia among persons with diabetes mellitus have not been reported. This study aimed to investigate the prevalence, biochemical characteristics, screening and management practices for dyslipidaemia among persons with diabetes mellitus, hypertension, and diabetes mellitus and hypertension comorbidity at Queen Elizabeth Central hospital in Blantyre, Malawi. Methods This was a cross-sectional study conducted in 2021. A total of 256 adult participants (diabetes mellitus = 100); hypertension = 100; both conditions = 56) were included. Medical data and anthropometric measurements were recorded. Blood samples were analysed for HbA1C and serum lipids. Associated risk factors for dyslipidaemia were also assessed. Results Dyslipidaemia was prevalent in 58%, 55%, and 70% of participants with diabetes mellitus, hypertension, and both conditions. Low-density lipoprotein cholesterol (LDL-C) dyslipidaemia was the most common in all participant groups. Participants with both diabetes and hypertension had 2.4 times (95% CI 1.2–4.6) increased risk of LDL-C dyslipidaemia than those with diabetes alone (p < 0.02). Being overweight or obese and age over 30 years were risk factors for dyslipidaemia in participants with diabetes mellitus alone (OR 1.3 (95% CI 1.1–1.6), p < 0.04, and OR 2.2 (95% CI 1.2–4.7) (p < 0.01), respectively. Overweight and obesity predicted LDL-C dyslipidaemia in hypertensive patients (OR 3.5 (95% CI 1.2–9.9) p < 0.001). Poorly controlled hypertension and the use of beta-blockers and thiazide diuretics predicted dyslipidaemia among patients with both diabetes mellitus and hypertension (OR 6.50 CI 1.45–29.19; and OR 5.20 CI 1.16–23.36 respectively). None of the participants had a lipogram performed before the study or were on lipid-lowering therapy. Conclusions Dyslipidaemia with LDL-C derangement was highly prevalent, especially in individuals with both diabetes mellitus and hypertension, and there was absent use of lipid-lowering therapy. Screening and managing dyslipidaemia should be reinforced to reduce the risk of cardiovascular complications in this population at increased risk.

show abstract